SCHEMBL2665951

SCHEMBL2665951

COC(=O)c1ccc(/C=C/c2cc(O)cc(O)c2)nc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.51
PTGS2 P35354 2/20 0.51
CA12 O43570 3/20 0.50
CA1 P00915 3/20 0.50
CA2 P00918 3/20 0.50
CA7 P43166 3/20 0.50
CA9 Q16790 3/20 0.50
CA14 Q9ULX7 3/20 0.50
KDM4E B2RXH2 3/20 0.49
L3MBTL1 Q9Y468 2/20 0.49
PTPN1 P18031 1/20 0.49
ALDH1A1 P00352 5/20 0.44
KMT2A Q03164 4/20 0.44
MAPT P10636 3/20 0.44
HPGD P15428 2/20 0.44
GLA P06280 1/20 0.44
P4HB P07237 1/20 0.43
PIM1 P11309 1/20 0.43
XDH P47989 1/20 0.42
MEN1 O00255 3/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6413331 0.84 L3MBTL1 (0.54) MAPK1CA1CA2KDM4EL3MBTL1
SCHEMBL6413338 0.84 L3MBTL1 (0.54) MAPK1CA1CA2KDM4EL3MBTL1
SCHEMBL2665962 0.82 KDM4E (0.54) MAPK1CA1CA2KDM4EL3MBTL1
SCHEMBL6641242 0.82 MAPK1 (0.51) MAPK1KDM4EL3MBTL1PTPN1ALDH1A1
SCHEMBL6641237 0.82 MAPK1 (0.51) MAPK1KDM4EL3MBTL1PTPN1ALDH1A1
SCHEMBL2400709 0.81 MAPT (0.62) MAPK1CA1CA2KDM4EL3MBTL1
SCHEMBL30644141 0.81 KMT2A (0.52) MAPK1KDM4EL3MBTL1PTPN1ALDH1A1
SCHEMBL2400706 0.81 MAPT (0.62) MAPK1CA1CA2KDM4EL3MBTL1
SCHEMBL26643204 0.81 KMT2A (0.52) MAPK1KDM4EL3MBTL1PTPN1ALDH1A1
SCHEMBL4255769 0.81 PTPN1 (0.71) PTGS2CA12CA1CA2CA7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070093535-A1 Vinyl phenyl derivatives as GLK activators ASTRAZENECA AB 2007-04-26 US disclosed
US-20070093535-A1 Vinyl phenyl derivatives as GLK activators ASTRAZENECA AB 2007-04-26 US disclosed
US-7199140-B2 Vinyl phenyl derivatives as GLK activators ASTRAZENECA AB (SE) 2007-04-03 US disclosed
US-7199140-B2 Vinyl phenyl derivatives as GLK activators ASTRAZENECA AB (SE) 2007-04-03 US disclosed
WO-2003000262-A1 VINYL PHENYL DERIVATIVES AS GLK ACTIVATORS ASTRAZENECA AB (SE) 2003-01-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070093535-A1 Vinyl phenyl derivatives as GLK activators GCK, GCKR, GK MAPK1 565/4885PTGS2 291/4885CA12 3710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.